NIH-funded research R01 grant

How low vitamin D after preterm birth may harm kidney development

Official title: Investigating the effect of dysregulated vitamin D metabolism on kidney development following preterm birth

Funded at University of Virginia · NIH-11326227 · Data updated 2026-11-12

This project explores whether low vitamin D around the time of preterm birth harms developing kidneys and the podocyte cells that protect kidney filtering.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startApril 1, 2024
Project endMarch 31, 2028
Funding year2026
Award (this year)$684,028
NIH project number5R01DK136989-03
Project IDNIH-11326227 on NIH RePORTER

Who could benefit from this research

Could help

People born preterm, parents of preterm infants, or young adults with a history of prematurity are the population most directly affected by this research.

Less likely to help

Full-term infants or people whose kidney disease is unrelated to prematurity may not directly benefit from these findings.

What this research studies

As a parent or patient, you should know researchers are studying how changes in vitamin D metabolism after preterm birth might reduce the active form of vitamin D in the newborn kidney. Using a mouse model of preterm birth they measure kidney gene expression, track podocyte number and Nphs1 levels, and examine local vitamin D pathway changes. The team connects these findings to the higher risk of proteinuria and chronic kidney disease seen after prematurity. Their approach aims to reveal whether correcting vitamin D signaling could protect developing kidney cells.

Why it matters

Potential benefit: If confirmed, this work could point to vitamin D strategies around preterm birth that protect podocytes and reduce long-term risk of chronic kidney disease.

How similar studies have gone: Previous animal studies show vitamin D can protect podocytes in glomerular disease, but applying this mechanism to preterm-related kidney development is relatively new.

Where this research is happening

  • University of Virginia
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Charlton, Jennifer R — University of Virginia
  • Study coordinator: Charlton, Jennifer R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.